Title
Roche: less frequent dosing for Phase 3 Huntington's clinical trial, easing burden on patients
Document Type
Blog Post
Publication Date
3-22-2019
Disciplines
Nervous System Diseases
Digital USD Citation
Serbin, Kenneth P., "Roche: less frequent dosing for Phase 3 Huntington's clinical trial, easing burden on patients" (2019). At Risk for Huntington's Disease. 269.
https://digital.sandiego.edu/huntingtons/269
